Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors

Data in Brief

Volumn 15, Issue , 2017, Pages 281-299

  Amata, Emanuele ^a   Marrazzo, Agostino ^a   Dichiara, Maria ^a   Modica, Maria N ^a   Salerno, Loredana ^a   Prezzavento, Orazio ^a   Nastasi, Giovanni ^a   Rescifina, Antonio ^a   Romeo, Giuseppe ^a   Pittalà, Valeria ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

2D QSAR; CORAL; FDA; Heme Oxygenase; pIC50 prediction

Indexed keywords

MOLECULAR GRAPHICS; PORPHYRINS;

2D-QSAR; CORAL; FDA; HEME OXYGENASE-1; HEME OXYGENASES; ISOFORMS; MOLECULAR GRAPHS; MOLECULAR HYBRID; PIC50 PREDICTION; QSAR MODEL;

COMPUTATIONAL CHEMISTRY;

EID: 85030709551     PISSN: None     EISSN: 23523409     Source Type: Journal    
DOI: 10.1016/j.dib.2017.09.036     Document Type: DP

References (15)

1. Amata, E., Pittala, V., Marrazzo, A., Parenti, C., Prezzavento, O., Arena, E., Nabavi, S.M., Salerno, L., Role of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries. Clin. Sci. 131 (2017), 1701–1712.
2. Pittala, V., Salerno, L., Romeo, G., Acquaviva, R., Di Giacomo, C., Sorrenti, V., Therapeutic potential of Caffeic Acid Phenethyl Ester (CAPE) in diabetes. Curr. Med. Chem., 2017 (in press).
3. Pittala, V., Vanella, L., Salerno, L., Romeo, G., Marrazzo, A., Di Giacomo, C., Sorrenti, V., Effects of polyphenolic derivatives on heme oxygenase-system in metabolic dysfunctions. Curr. Med. Chem., 2017, 10.2174/0929867324666170616110748 in press.
4. Salerno, L., Pittala, V., Romeo, G., Modica, M.N., Marrazzo, A., Siracusa, M.A., Sorrenti, V., Di Giacomo, C., Vanella, L., Parayath, N.N., Greish, K., Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines. Eur. J. Med. Chem. 96 (2015), 162–172.
5. Salerno, L., Pittala, V., Romeo, G., Modica, M.N., Siracusa, M.A., Di Giacomo, C., Acquaviva, R., Barbagallo, I., Tibullo, D., Sorrenti, V., Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties. Bioorg. Med. Chem. 21 (2013), 5145–5153.
6. Pittala, V., Salerno, L., Romeo, G., Modica, M.N., Siracusa, M.A., A focus on heme oxygenase-1 (HO-1) inhibitors. Curr. Med. Chem. 20 (2013), 3711–3732.
7. Sorrenti, V., Guccione, S., Di Giacomo, C., Modica, M.N., Pittala, V., Acquaviva, R., Basile, L., Pappalardo, M., Salerno, L., Evaluation of Imidazole-based compounds as heme oxygenase-1 inhibitors. Chem. Biol. Drug Des. 80 (2012), 876–886.
8. Toropova, A.P., Toropov, A.A., Veselinovic, J.B., Miljkovic, F.N., Veselinovic, A.M., QSAR models for HEPT derivatives as NNRTI inhibitors based on Monte Carlo method. Eur. J. Med. Chem. 77 (2014), 298–305.
9. Amata, E., Xi, H., Colmenarejo, G., Gonzalez-Diaz, R., Cordon-Obras, C., Berlanga, M., Manzano, P., Erath, J., Roncal, N.E., Lee, P.J., Leed, S.E., Rodriguez, A., Sciotti, R.J., Navarro, M., Pollastri, M.P., Identification of “Preferred” human kinase inhibitors for sleeping sickness lead discovery. Are some kinases better than others for inhibitor repurposing?. ACS Infect. Dis. 2 (2016), 180–186.
10. Diaz, R., Luengo-Arratta, S.A., Seixas, J.D., Amata, E., Devine, W., Cordon-Obras, C., Rojas-Barros, D.I., Jimenez, E., Ortega, F., Crouch, S., Colmenarejo, G., Fiandor, J.M., Martin, J.J., Berlanga, M., Gonzalez, S., Manzano, P., Navarro, M., Pollastri, M.P., Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign. PLoS Negl. Trop. Dis., 8, 2014, e3253.
11. Nastasi, G., Miceli, C., Pittala, V., Modica, M.N., Prezzavento, O., Romeo, G., Rescifina, A., Marrazzo, A., Amata, E., S2RSLDB: a comprehensive manually curated, internet-accessible database of the sigma-2 receptor selective ligands. J. Chemin., 9, 2017, 3.
12. Amata, E., Marrazzo, A., Dichiara, M., Modica, M.N., Salerno, L., Prezzavento, O., Nastasi, G., Rescifina, A., Romeo, G., Pittala, V., Heme oxygenase database (HemeOxDB) and QSAR analysis of isoform 1 inhibitors. ChemMedChem, 2017, 10.1002/cmdc.201700321 in press.
13. Toropova, A.P., Toropov, A.A., Benfenati, E., CORAL: prediction of binding affinity and efficacy of thyroid hormone receptor ligands. Eur. J. Med. Chem. 101 (2015), 452–461.
14. Rescifina, A., Floresta, G., Marrazzo, A., Parenti, C., Prezzavento, O., Nastasi, G., Dichiara, M., Amata, E., Development of a Sigma-2 receptor affinity filter through a Monte Carlo based QSAR analysis. Eur. J. Pharm. Sci. 106 (2017), 94–101.
15. Rescifina, A., Floresta, G., Marrazzo, A., Parenti, C., Prezzavento, O., Nastasi, G., Dichiara, M., Amata, E., Sigma-2 receptor ligands QSAR model dataset. Data Brief 13 (2017), 514–535.